Drug discoverers chart path to tackling data irreproducibility

Researchers from across the biomedical research community met in October to discuss solutions to the 'irreproducibility epidemic', which has been re-emphasized by new data from Novartis and Sigma-Aldrich.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dolgin, E. Drug discoverers chart path to tackling data irreproducibility. Nat Rev Drug Discov 13, 875–876 (2014). https://doi.org/10.1038/nrd4488

Download citation

Further reading


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing